<DOC>
	<DOCNO>NCT02967302</DOCNO>
	<brief_summary>To investigate pain inflammatory parameter ( cytokine , immune cell ) knee joint tissue chronic arthritis patient follow intraarticular ( i.a . ) injection morphine , standard steroid placebo . The primary hypothesis i.a . morphine result significantly low pain score supplemental analgesic consumption placebo first week injection , efficacy comparable standard i.a . steroid ( triamcinolone ) medication .</brief_summary>
	<brief_title>NEUROIMPA - Intraarticular Application Opioids Chronic Arthritis Knee Joint</brief_title>
	<detailed_description>3 arm , double blind , placebo control , prospective , mo-nocenter study , conduct Department Rheumatology , Charité University Medicine Berlin , Cam-pus Benjamin Franklin collaboration several rheu-matology orthopedic practice Berlin area . Ultra-sound guide synovial needle biopsy intervention perform CBF . Eligible patient treat either morphine 3 mg i.a. , NaCl 0.9 % i.a . triamcinolone 40 mg i.a . Baseline . The entire study period 2 week per patient . Assessment primary outcome parameter week 1 . The patient monitor closely throughout entire study period total 4 visit ( screen , baseline , week 1 , week 2 ) . Safety data collect adverse event form , vital parameter , physical examination laboratory test dur-ing whole study .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>1 . Clinically detectable and/or ultrasoundvisible knee effusion part spondyloarthritis ( Assessments SpondyloArthritis international Society , ASAS criterion ) , Rheumatoid Arthritis , RA ( accord American College Rheumatology , ACR criterion ) , undifferentiated mono oligoarthritis , Osteoarthritis knee , OA . 2. baseline pain score ( 100 mm Visual Analogue Scale , VAS ) &gt; 40 mm ; 3. male female patient , age ≥18 80 year , 4. body weight 50 90 kg . 5 . Able willing give write informed consent comply requirement study protocol . Only patient give write informed consent include trial . 6 . If female : either childbearing potential ( menopausal since 1 year surgically sterile ) willing able practice reliable method contraception throughout study pearl index &lt; 1 . Reliable method contraception : condom plus method : implant , injecatbles , combine oral contraceptive , intrauterine device , initiate least 90 day prior screen . Further reliable method vasectomise partner ( least 1 year prior enrolment ) , sexually abstinent , surgically sterilize ( include hysterectomy ) , postmenopausal define least 1 year spontaneous amenorrhea ( questionable case blood sample simultaneous level follicle stimulate hormone ( FSH ) 40 U/l estradiol 30 nl/l confirmatory ) . 7 . If male : either childbearing potential ( surgically sterilize , e.g . vasectomy ) willing able practice reliable method contraception pearl index &lt; 1 ( see inclusion criterium 6 ) throughout study . 1 . Severe cardiovascular , respiratory , metabolic , neurological , psychiatric disorder ; current bacterial infection especially knee 2. abuse analgesic , benzodiazepine , alcohol ; `` hard drug '' 3. pregnancy , lactation 4. biopsy thrombocyte count &lt; 100/nl , Quick &lt; 50 % 5. intake anticoagulant , antiaggregants monotherapy ASS 100 allow 6. participation investigational trial last 30 day 5 HLT whichever longer 7. treatment intraarticular steroid past 4 week select joint . 8 . Patients history severe psychiatric illness , might interfere patient 's ability understand requirement study assessment . 9 . Patients institutionalised due regulatory juridical order . Patients employee investigator study site , direct involvement propose study study direction investigator study site , well family member employee investigator . 10 . Known hypersensitivity component study medication morphine triamcinolone , ileus , respiratory depression , severe chronic obstructive airway disease , acute abdomen , coagulopathy and/ infection injection site , instability inject joint , psoriatic skin manifestation injection site , periarticular calcification , nonvascularized bone necrosis , tendon rupture , Charcotjoint .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>knee arthritis , morphine , local injection , pain</keyword>
</DOC>